Lawrence S. Argetsinger

3.7k total citations · 1 hit paper
40 papers, 3.0k citations indexed

About

Lawrence S. Argetsinger is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lawrence S. Argetsinger has authored 40 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Oncology and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lawrence S. Argetsinger's work include Cytokine Signaling Pathways and Interactions (21 papers), Growth Hormone and Insulin-like Growth Factors (17 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Lawrence S. Argetsinger is often cited by papers focused on Cytokine Signaling Pathways and Interactions (21 papers), Growth Hormone and Insulin-like Growth Factors (17 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Lawrence S. Argetsinger collaborates with scholars based in United States, Australia and Denmark. Lawrence S. Argetsinger's co-authors include Christin Carter‐Su, George S. Campbell, Bruce A. Witthuhn, Olli Silvennoinen, Morris F. White, Nils Billestrup, Martin G. Myers, Paul A. Kelly, Jules A. Shafer and J N Ihle and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Lawrence S. Argetsinger

38 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

1993 821 citations Lawrence S. Argetsinger, George S. Campbell et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence S. Argetsinger United States	23	1.4k	1.3k	1.2k	502	439	40	3.0k
Amilcar Flores‐Morales Sweden	36	1.7k 1.2×	964 0.7×	1.0k 0.9×	465 0.9×	410 0.9×	74	3.6k
George S. Campbell United States	16	1.4k 1.0×	1.1k 0.8×	1.7k 1.4×	660 1.3×	305 0.7×	25	2.9k
Prabha A. Ram United States	17	909 0.6×	1.2k 0.9×	1.3k 1.1×	486 1.0×	427 1.0×	18	2.6k
Henry B. Sadowski United States	17	1.0k 0.7×	248 0.2×	946 0.8×	501 1.0×	383 0.9×	23	2.2k
Michał Bieńkowski Poland	24	1.2k 0.8×	293 0.2×	322 0.3×	271 0.5×	260 0.6×	80	2.3k
Suhad Ali Canada	30	1.5k 1.1×	404 0.3×	1.1k 0.9×	370 0.7×	293 0.7×	58	2.4k
Jaap Twisk Netherlands	27	1.5k 1.0×	522 0.4×	754 0.6×	242 0.5×	884 2.0×	49	2.9k
Alan Cheng United States	26	1.9k 1.3×	207 0.2×	593 0.5×	943 1.9×	195 0.4×	45	3.1k
Chandi Griffin United States	26	1.3k 0.9×	717 0.6×	265 0.2×	113 0.2×	299 0.7×	48	2.6k
Elisabeth Fayard France	13	1.3k 0.9×	211 0.2×	545 0.5×	258 0.5×	488 1.1×	15	2.1k

Countries citing papers authored by Lawrence S. Argetsinger

Since Specialization

Citations

This map shows the geographic impact of Lawrence S. Argetsinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence S. Argetsinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence S. Argetsinger more than expected).

Fields of papers citing papers by Lawrence S. Argetsinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence S. Argetsinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence S. Argetsinger. The network helps show where Lawrence S. Argetsinger may publish in the future.

Co-authorship network of co-authors of Lawrence S. Argetsinger

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence S. Argetsinger. A scholar is included among the top collaborators of Lawrence S. Argetsinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence S. Argetsinger. Lawrence S. Argetsinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Argetsinger, Lawrence S., et al.. (2023). Role of the Beta and Gamma Isoforms of the Adapter Protein SH2B1 in Regulating Energy Balance. Endocrinology. 164(5).

Doche, Michael E., et al.. (2017). Phosphorylation of the Unique C-Terminal Tail of the Alpha Isoform of the Scaffold Protein SH2B1 Controls the Ability of SH2B1α To Enhance Nerve Growth Factor Function. Molecular and Cellular Biology. 38(6). 7 indexed citations

Carter‐Su, Christin, Jessica Schwartz, & Lawrence S. Argetsinger. (2015). Growth hormone signaling pathways. Growth Hormone & IGF Research. 28. 11–15. 79 indexed citations

Su, Hsiao-Wen, Nathan Lanning, David L. Morris, et al.. (2013). Phosphorylation of the adaptor protein SH2B1βregulates its ability to enhance growth hormone (GH)-dependent macrophage motility. Journal of Cell Science. 126(Pt 8). 1733–43. 18 indexed citations

Doche, Michael E., Elena G. Bochukova, Laura R. Pearce, et al.. (2013). Human SH2B1 mutations are associated with maladaptive behaviors and obesity. Journal of Clinical Investigation. 123(1). 526–526. 2 indexed citations

Argetsinger, Lawrence S., Jeanne A. Stuckey, Scott Robertson, et al.. (2010). Tyrosines 868, 966, and 972 in the Kinase Domain of JAK2 Are Autophosphorylated and Required for Maximal JAK2 Kinase Activity. Molecular Endocrinology. 24(5). 1062–1076. 26 indexed citations

Argetsinger, Lawrence S., et al.. (2006). Phosphorylation of JAK2 at Serine 523: a Negative Regulator of JAK2 That Is Stimulated by GrowthHormone and Epidermal Growth Factor. Molecular and Cellular Biology. 26(11). 4052–4062. 46 indexed citations

Argetsinger, Lawrence S., et al.. (2004). Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its Activity. Molecular and Cellular Biology. 24(11). 4955–4967. 116 indexed citations

O’Brien, Karen B., Lawrence S. Argetsinger, Maria Diakonova, & Christin Carter‐Su. (2003). YXXL Motifs in SH2-B Are Phosphorylated by JAK2, JAK1, and Platelet-derived Growth Factor Receptor and Are Required for Membrane Ruffling. Journal of Biological Chemistry. 278(14). 11970–11978. 32 indexed citations

10.

Rui, Liangyou, et al.. (2000). Platelet-derived Growth Factor and Lysophosphatidic Acid Inhibit Growth Hormone Binding and Signaling via a Protein Kinase C-dependent Pathway. Journal of Biological Chemistry. 275(4). 2885–2892. 18 indexed citations

11.

Stofega, Mary R., Lawrence S. Argetsinger, Hongyang Wang, Axel Ullrich, & Christin Carter‐Su. (2000). Negative Regulation of Growth Hormone Receptor/JAK2 Signaling by Signal Regulatory Protein α. Journal of Biological Chemistry. 275(36). 28222–28229. 56 indexed citations

12.

Carter‐Su, Christin, Anthony P. King, Lisa S. Smit, et al.. (1997). Molecular Mechanisms of Growth Hormone Action. Journal of Animal Science. 75. 1–10. 8 indexed citations

13.

Argetsinger, Lawrence S. & Christin Carter‐Su. (1996). Growth Hormone Signalling Mechanisms: Involvement of the Tyrosine Kinase JAK2. Hormone Research. 45(1). 22–24. 39 indexed citations

14.

Argetsinger, Lawrence S., Gunnar Norstedt, Nils Billestrup, Morris F. White, & Christin Carter‐Su. (1996). Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Utilize Insulin Receptor Substrate-2 in Intracellular Signaling. Journal of Biological Chemistry. 271(46). 29415–29421. 104 indexed citations

15.

Carter‐Su, Christin, Anthony P. King, Lawrence S. Argetsinger, et al.. (1996). Signalling Pathway of GH.. Endocrine Journal. 43(Suppl). S65–S70. 40 indexed citations

16.

Argetsinger, Lawrence S., et al.. (1995). Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Promoted Tyrosyl Phosphorylation of Insulin Receptor Substrate-1. Journal of Biological Chemistry. 270(24). 14685–14692. 206 indexed citations

17.

Carter‐Su, Christin, Lawrence S. Argetsinger, George S. Campbell, et al.. (1994). The Identification of JAK2 Tyrosine Kinase as a Signaling Molecule for Growth Hormone. Experimental Biology and Medicine. 206(3). 210–215. 20 indexed citations

18.

Argetsinger, Lawrence S., et al.. (1993). Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell. 74(2). 237–244. 821 indexed citations breakdown →

19.

Argetsinger, Lawrence S., et al.. (1990). Isolation of a catalytically competent phosphorylated tyrosine kinase from Rous sarcoma virus-induced rat tumor by immunoadsorption to and hapten elution from phosphotyrosine binding antibodies. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1037(3). 380–387. 3 indexed citations

20.

Stred, Susan E., et al.. (1990). Demonstration of Growth Hormone (GH) Receptor- Associated Tyrosine Kinase Activity in Multiple GHResponsive Cell Types*. Endocrinology. 127(5). 2506–2516. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact